HIV-producing resting T cells monopolize virus production, associated PANoptosis, and persistence in lymphoid tissue
Lijie Duan, Mark A SandersiD, Stephen W. WietgrefeiD, Defeng TianiD, Peter J. SoutherniD, Jodi L. Anderson, Garritt Wieking, Timothy W. SchackeriD, Ashley T. HaaseiD
Abstract
O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=147 SRC="FIGDIR/small/703840v1_ufig1.gif" ALT="Figure 1"> View larger version (43K): org.highwire.dtl.DTLVardef@167c265org.highwire.dtl.DTLVardef@10ba2beorg.highwire.dtl.DTLVardef@e97e06org.highwire.dtl.DTLVardef@150c07c_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOGraphic:C_FLOATNO In chronic HIV infection, HIV is produced before antiretroviral therapy (ART) by resting CD4+ T cells in lymphoid tissue germinal centers. Virus production is associated with destruction of T cells, follicular dendritic cells (FDCs), and B cells required for humoral immune responses by PANoptosis (apotosis, pyroptosis and necroptosis) mediated by the PANoptosome, a cellular structure that incorporates cell contents and programmed cell death pathways in a nodal latticework that mediates cell emptying and disruption in progressive stages indicated by the numbers. During ART, persistent HIV-producing resting T cells represent an immediate source of virus for infection rebound on treatment interruption. C_FIG Activated CD4+ T cells have long been considered the principal source of HIV production before treatment and reactivated latently infected cells the source of virus rebound on treatment interruption, based largely on studies of peripheral blood T cells. Here we show before ART in the lymphoid tissue reservoir that HIV-producing resting CD4+ T cells are essentially the sole source of virus production in germinal centers. Virus is produced in infection complexes of virus bearing follicular dendritic cells (FDCs) that induce high multiplicity multi-HIV-DNA copy infections in overlying resting T cells. HIV production is associated with destruction by PANoptosis (pyroptosis, necroptosis and apoptosis) of interacting antibody-producing populations of FDCs, T cells and B cells. PANoptosis is mediated by the PANoptosome, visualized and defined here as a cellular structure incorporating cytoplasmic and nuclear contents and programmed cell death pathway components in a nodal latticework that executes cell emptying and disruption. During ART, HIV-producing resting T cells persist in lymphoid tissues when virus is undetectable in peripheral blood. These HIV-producing resting T cells that persist during ART represent an immediate source of virus to reignite infection on treatment interruption and are thus identified as an important new target for functional cure strategies.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Productive and latent HIV infections originate in resting CD4+ T cells
S. Wietgrefe, J. Anderson, … A. T. Haase·bioRxiv·Aug 26, 2022
- HIV-specific T-cell responses reflect substantive in vivo interactions with infected cells despite long-term therapy
E. Stevenson, A. Ward, … R. B. Jones·bioRxiv·Aug 28, 2020
- A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation
D. B. Reeves, E. R. Duke, … J. T. Schiffer·bioRxiv·Sep 7, 2018
- Ongoing lymphoid HIV production drives pyroptosis and GLP-1 counter-regulation in ART-suppressed infection
Peter A Crawford, Joshua Rhein, … Timothy W. Schacker·bioRxiv·Jan 10, 2026
- Therapeutic CD8+T cell tissue retention and immunomodulation during ART interruption fails to prevent SIV rebound
María Betina Pampena, Sadia Samer, … Michael R. Betts·Proceedings of the National Academy of SciencesPeer-reviewed·Aug 14, 2025
- Antigen stimulation drives clonal expansion of latent CD4+ T cells using a full-length HIV latency reporter
Nnamdi M. Ikeogu, Oluwaseun Ajibola, … Thomas T. Murooka·bioRxiv·Sep 4, 2025